Gastrointestinal disorders associated with migraine: A comprehensive review

World Journal of Gastroenterology

Volumn 22, Issue 36, 2016, Pages 8149-8160

  Cámara Lemarroy, Carlos R ^a   Rodriguez Gutierrez, Rene ^a   Monreal Robles, Roberto ^a   Marfil Rivera, Alejandro ^a  

^a HOSPITAL UNIVERSITARIO DR JOSÉ ELEUTERIO GONZÁLEZ   (Mexico)

Author keywords

Gastrointestinal diseases; Headache; Microbiota; Migraine; Review

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE; CHOLECYSTOKININ;

AUTONOMIC NERVOUS SYSTEM; CELIAC DISEASE; COMORBIDITY; DIGESTIVE SYSTEM FUNCTION DISORDER; DISEASE ASSOCIATION; DISEASE SEVERITY; ENVIRONMENTAL RISK FACTOR; GASTROINTESTINAL DISEASE; GUT MICROBIOME; HELICOBACTER INFECTION; HEPATOBILIARY DISEASE; HIGH RISK POPULATION; HUMAN; INTESTINE FLORA; INTESTINE INNERVATION; IRRITABLE COLON; MICROBIOME; MIGRAINE; MISCELLANEOUS NAMED GROUPS; NONHUMAN; PATIENTS WITH MIGRAINE; PROTEIN FUNCTION; REVIEW; RISK FACTOR; SEROTONINERGIC SYSTEM; STOMACH EMPTYING; STOMACH PARESIS; BILIARY TRACT DISEASE; COMPLICATION; GASTROINTESTINAL TRACT; HELICOBACTER PYLORI; INFLAMMATION; LIVER DISEASE; PATHOPHYSIOLOGY;

BILIARY TRACT DISEASES; CELIAC DISEASE; ENTERIC NERVOUS SYSTEM; GASTROINTESTINAL MICROBIOME; GASTROINTESTINAL TRACT; GASTROPARESIS; HELICOBACTER INFECTIONS; HELICOBACTER PYLORI; HUMANS; INFLAMMATION; IRRITABLE BOWEL SYNDROME; LIVER DISEASES; MIGRAINE DISORDERS;

EID: 84991107479     PISSN: 10079327     EISSN: 22192840     Source Type: Journal    
DOI: 10.3748/wjg.v22.i36.8149     Document Type: Review

References (105)

1. Headache Classification Committee of the International Headache Society (IHS). The International Classification of Headache Disorders, 3rd edition (beta version). Cephalalgia 2013; 33: 629-808 [PMID: 23771276 DOI: 10.1177/0333102413485658]
2. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology 2007; 68: 343-349 [PMID: 17261680 DOI: 10.1212/01.wnl.0000252808.97649.21]
3. Victor TW, Hu X, Campbell JC, Buse DC, Lipton RB. Migraine prevalence by age and sex in the United States: a life-span study. Cephalalgia 2010; 30: 1065-1072 [PMID: 20713557 DOI: 10.117 7/0333102409355601]
4. Stovner Lj, Hagen K, Jensen R, Katsarava Z, Lipton R, Scher A, Steiner T, Zwart JA. The global burden of headache: a documentation of headache prevalence and disability worldwide. Cephalalgia 2007; 27: 193-210 [PMID: 17381554 DOI: 10.1111/ j.1468-2982.2007.01288.x]
5. Valade D. Chronic migraine. Rev Neurol (Paris) 2013; 169: 419-426 [PMID: 23602118 DOI: 10.1016/j.neurol.2013.01.629]
6. Natoli JL, Manack A, Dean B, Butler Q, Turkel CC, Stovner L, Lipton RB. Global prevalence of chronic migraine: a systematic review. Cephalalgia 2010; 30: 599-609 [PMID: 19614702 DOI: 10.1111/j.1468-2982.2009.01941.x]
7. Ferrari MD, Klever RR, Terwindt GM, Ayata C, van den Maagdenberg AM. Migraine pathophysiology: lessons from mouse models and human genetics. Lancet Neurol 2015; 14: 65-80 [PMID: 25496898 DOI: 10.1016/s1474-4422(14)70220-0]
8. Noseda R, Burstein R. Migraine pathophysiology: anatomy of the trigeminovascular pathway and associated neurological symptoms, cortical spreading depression, sensitization, and modulation of pain. Pain 2013; 154 Suppl 1: S44-S53 [PMID: 23891892 DOI: 10.1016/j.pain.2013.07.021]
9. Burstein R, Noseda R, Borsook D. Migraine: multiple processes, complex pathophysiology. J Neurosci 2015; 35: 6619-6629 [PMID: 25926442 DOI: 10.1523/jneurosci.0373-15.2015]
10. Aamodt AH, Stovner LJ, Hagen K, Zwart JA. Comorbidity of headache and gastrointestinal complaints. The Head-HUNT Study. Cephalalgia 2008; 28: 144-151 [PMID: 18197884 DOI: 10.1111/ j.1468-2982.2007.01486.x]
11. Alvarez-Arellano L, Maldonado-Bernal C. Helicobacter pylori and neurological diseases: Married by the laws of inflammation. World J Gastrointest Pathophysiol 2014; 5: 400-404 [PMID: 25400983 DOI: 10.4291/wjgp.v5.i4.400]
12. Gasbarrini A, Franceschi F, Armuzzi A, Ojetti V, Candelli M, Torre ES, De Lorenzo A, Anti M, Pretolani S, Gasbarrini G. Extradigestive manifestations of Helicobacter pylori gastric infection. Gut 1999; 45 Suppl 1: I9-I12 [PMID: 10457029 DOI: 10.1136/gut.45.2008.i9]
13. Mavromichalis I, Zaramboukas T, Giala MM. Migraine of gastrointestinal origin. Eur J Pediatr 1995; 154: 406-410 [PMID: 7641777 DOI: 10.1007/BF02072116]
14. Gasbarrini A, De Luca A, Fiore G, Franceschi F, Ojetti VV, Torre ES, Di Campli C, Candelli M, Pola R, Serricchio M, Tondi P, Gasbarrini G, Pola P, Giacovazzo M. Primary Headache and Helicobacter Pylori. Int J Angiol 1998; 7: 310-312 [PMID: 9716793 DOI: 10.1007/s005479900121]
15. Gasbarrini A, De Luca A, Fiore G, Gambrielli M, Franceschi F, Ojetti V, Torre ES, Gasbarrini G, Pola P, Giacovazzo M. Beneficial effects of Helicobacter pylori eradication on migraine. Hepatogastroenterology 1998; 45: 765-770 [PMID: 9684130]
16. Pinessi L, Savi L, Pellicano R, Rainero I, Valfrè W, Gentile S, Cossotto D, Rizzetto M, Ponzetto A. Chronic Helicobacter pylori infection and migraine: a case-control study. Headache 2000; 40: 836-839 [PMID: 11135029 DOI: 10.1046/j.1526-4610.2000.00151.x]
17. Gasbarrini A, Gabrielli M, Fiore G, Candelli M, Bartolozzi F, De Luca A, Cremonini F, Franceschi F, Di Campli C, Armuzzi A, Ojetti V, Serricchio M, Pola R, Gasbarrini G, Giacovazzo M, Pola P. Association between Helicobacter pylori cytotoxic type I CagApositive strains and migraine with aura. Cephalalgia 2000; 20: 561-565 [PMID: 11075839 DOI: 10.1046/j.1468-2982.2000.00077.x]
18. Tunca A, Türkay C, Tekin O, Kargili A, Erbayrak M. Is Helicobacter pylori infection a risk factor for migraine? A case-control study. Acta Neurol Belg 2004; 104: 161-164 [PMID: 15742606]
19. Yiannopoulou KG, Efthymiou A, Karydakis K, Arhimandritis A, Bovaretos N, Tzivras M. Helicobacter pylori infection as an environmental risk factor for migraine without aura. J Headache Pain 2007; 8: 329-333 [PMID: 18071631 DOI: 10.1007/ s10194-007-0422-7]
20. Su J, Zhou XY, Zhang GX. Association between Helicobacter pylori infection and migraine: a meta-analysis. World J Gastroenterol 2014; 20: 14965-14972 [PMID: 25356058 DOI: 10.3748/wjg.v20.i40.14965]
21. Ansari B, Basiri K, Meamar R, Chitsaz A, Nematollahi S. Association of Helicobacter pylori antibodies and severity of migraine attack. Iran J Neurol 2015; 14: 125-129 [PMID: 26622976]
22. Faraji F, Zarinfar N, Zanjani AT, Morteza A. The effect of Helicobacter pylori eradication on migraine: a randomized, double blind, controlled trial. Pain Physician 2012; 15: 495-498 [PMID: 23159967]
23. Ciancarelli I, Di Massimo C, Tozzi-Ciancarelli MG, De Matteis G, Marini C, Carolei A. Helicobacter pylori infection and migraine. Cephalalgia 2002; 22: 222-225 [PMID: 12047462 DOI: 10.1046/ j.1468-2982.2002.00354.x]
24. Tunca A, Ardiçoǧlu Y, Kargili A, Adam B. Migraine, Helicobacter pylori, and oxidative stress. Helicobacter 2007; 12: 59-62 [PMID: 17241302 DOI: 10.1111/j.1523-5378.2007.00470.x]
25. Kang JW, Shin YI. The role of interleukin 10 in the associations between migraine and Helicobacter pylori infection. Pain Physician 2013; 16: E450 [PMID: 23877472]
26. Munno I, Marinaro M, Bassi A, Cassiano MA, Causarano V, Centonze V. Immunological aspects in migraine: increase of IL-10 plasma levels during attack. Headache 2001; 41: 764-767 [PMID: 11576199 DOI: 10.1046/j.1526-4610.2001.01140.x]
27. Cernuda-Morollón E, Larrosa D, Ramón C, Vega J, Martínez-Camblor P, Pascual J. Interictal increase of CGRP levels in peripheral blood as a biomarker for chronic migraine. Neurology 2013; 81: 1191-1196 [PMID: 23975872 DOI: 10.1212/WNL.0b013e3182a6cb72]
28. Yang H, Zou Y, Zhang X. [Determination of serum calicotonin gene-related peptide in patients with duodenal ulcer infected with Helicobacter pylori]. Hunan Yike Daxue Xuebao 1999; 24: 273-274 [PMID: 12016804]
29. Savi L, Ribaldone DG, Fagoonee S, Pellicano R. Is Helicobacter pylori the infectious trigger for headache?: A review. Infect Disord Drug Targets 2013; 13: 313-317 [PMID: 24304354 DOI: 10.2174/ 1871526513666131201125021]
30. Chang FY, Lu CL. Irritable bowel syndrome and migraine: bystanders or partners? J Neurogastroenterol Motil 2013; 19: 301-311 [PMID: 23875096 DOI: 10.5056/jnm.2013.19.3.301]
31. Riedl A, Schmidtmann M, Stengel A, Goebel M, Wisser AS, Klapp BF, Mönnikes H. Somatic comorbidities of irritable bowel syndrome: a systematic analysis. J Psychosom Res 2008; 64: 573-582 [PMID: 18501257 DOI: 10.1016/j.jpsychores.2008.02.021]
32. Whitehead WE, Palsson O, Jones KR. Systematic review of the comorbidity of irritable bowel syndrome with other disorders: what are the causes and implications? Gastroenterology 2002; 122: 1140-1156 [PMID: 11910364 DOI: 10.1053/gast.2002.32392]
33. Jones R, Lydeard S. Irritable bowel syndrome in the general population. BMJ 1992; 304: 87-90 [PMID: 1737146 DOI: 10.1136/ bmj.304.6819.87]
34. Tietjen GE, Herial NA, Hardgrove J, Utley C, White L. Migraine comorbidity constellations. Headache 2007; 47: 857-865 [PMID: 17578536 DOI: 10.1111/j.1526-4610.2007.00814.x]
35. Vandvik PO, Wilhelmsen I, Ihlebaek C, Farup PG. Comorbidity of irritable bowel syndrome in general practice: a striking feature with clinical implications. Aliment Pharmacol Ther 2004; 20: 1195-1203 [PMID: 15569123 DOI: 10.1111/j.1365-2036.2004.02250.x]
36. Cole JA, Rothman KJ, Cabral HJ, Zhang Y, Farraye FA. Migraine, fibromyalgia, and depression among people with IBS: a prevalence study. BMC Gastroenterol 2006; 6: 26 [PMID: 17007634 DOI: 10.1186/1471-230x-6-26]
37. Lau CI, Lin CC, Chen WH, Wang HC, Kao CH. Association between migraine and irritable bowel syndrome: a populationbased retrospective cohort study. Eur J Neurol 2014; 21: 1198-1204 [PMID: 24838228 DOI: 10.1111/ene.12468]
38. Guthrie EA, Creed FH, Whorwell PJ, Tomenson B. Outpatients with irritable bowel syndrome: a comparison of first time and chronic attenders. Gut 1992; 33: 361-363 [PMID: 1568655 DOI: 10.1136/gut.33.3.361]
39. Park JW, Cho YS, Lee SY, Kim ES, Cho H, Shin HE, Suh GI, Choi MG. Concomitant functional gastrointestinal symptoms influence psychological status in Korean migraine patients. Gut Liver 2013; 7: 668-674 [PMID: 24312707 DOI: 10.5009/ gnl.2013.7.6.668]
40. Aydinlar EI, Dikmen PY, Tiftikci A, Saruc M, Aksu M, Gunsoy HG, Tozun N. IgG-based elimination diet in migraine plus irritable bowel syndrome. Headache 2013; 53: 514-525 [PMID: 23216231 DOI: 10.1111/j.1526-4610.2012.02296.x]
41. Aurora SK, Papapetropoulos S, Kori SH, Kedar A, Abell TL. Gastric stasis in migraineurs: etiology, characteristics, and clinical and therapeutic implications. Cephalalgia 2013; 33: 408-415 [PMID: 23463252 DOI: 10.1177/0333102412473371]
42. Carstairs LS. Headache and gastric emptying time. Proc R Soc Med 1958; 51: 790-791; discussion 791-793 [PMID: 13601720]
43. Volans GN. Migraine and drug absorption. Clin Pharmacokinet 1978; 3: 313-318 [PMID: 354637 DOI: 10.2165/00003088-197803 040-00004]
44. Tokola RA, Neuvonen PJ. Effect of migraine attacks on paracetamol absorption. Br J Clin Pharmacol 1984; 18: 867-871 [PMID: 6529526 DOI: 10.1111/j.1365-2125.1984.tb02557.x]
45. Boyle R, Behan PO, Sutton JA. A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol 1990; 30: 405-409 [PMID: 2223419 DOI: 10.1111/j.1365-2125.1990.tb03791.x]
46. De Ponti F. Pharmacology of emesis and gastrointestinal motility: implications for migraine. Funct Neurol 2000; 15 Suppl 3: 43-49 [PMID: 11200800]
47. Aurora SK, Kori SH, Barrodale P, McDonald SA, Haseley D. Gastric stasis in migraine: more than just a paroxysmal abnormality during a migraine attack. Headache 2006; 46: 57-63 [PMID: 16412152 DOI: 10.1111/j.1526-4610.2006.00311.x]
48. Pucci E, Di Stefano M, Miceli E, Corazza GR, Sandrini G, Nappi G. Patients with headache and functional dyspepsia present mealinduced hypersensitivity of the stomach. J Headache Pain 2005; 6: 223-226 [PMID: 16362670 DOI: 10.1007/s10194-005-0191-0]
49. Aurora S, Kori S, Barrodale P, Nelsen A, McDonald S. Gastric stasis occurs in spontaneous, visually induced, and interictal migraine. Headache 2007; 47: 1443-1446 [PMID: 17868348 DOI: 10.1111/j.1526-4610.2007.00922.x]
50. Yalcin H, Okuyucu EE, Ucar E, Duman T, Yilmazer S. Changes in liquid emptying in migraine patients: diagnosed with liquid phase gastric emptying scintigraphy. Intern Med J 2012; 42: 455-459 [PMID: 22498119 DOI: 10.1111/j.1445-5994.2012.02741.x]
51. Yu YH, Jo Y, Jung JY, Kim BK, Seok JW. Gastric emptying in migraine: a comparison with functional dyspepsia. J Neurogastroenterol Motil 2012; 18: 412-418 [PMID: 23106002 DOI: 10.5056/jnm.2012.18.4.412]
52. Lee KJ. Gastric emptying in patients with functional dyspepsia and patients with migraine. J Neurogastroenterol Motil 2013; 19: 116-117 [PMID: 23350061 DOI: 10.5056/jnm.2013.19.1.116]
53. Parkman HP. Migraine and gastroparesis from a gastroenterologist's perspective. Headache 2013; 53 Suppl 1: 4-10 [PMID: 23721284 DOI: 10.1111/head.12112]
54. Krymchantowski AV, Filho PF, Bigal ME. Rizatriptan vs. rizatriptan plus trimebutine for the acute treatment of migraine: a double-blind, randomized, cross-over, placebo-controlled study. Cephalalgia 2006; 26: 871-874 [PMID: 16776704 DOI: 10.1111/ j.1468-2982.2006.01136.x]
55. Inaloo S, Dehghani SM, Hashemi SM, Heydari M, Heydari ST. Comorbidity of headache and functional constipation in children: a cross-sectional survey. Turk J Gastroenterol 2014; 25: 508-511 [PMID: 25417610 DOI: 10.5152/tjg.2014.6183]
56. Park MN, Choi MG, You SJ. The relationship between primary headache and constipation in children and adolescents. Korean J Pediatr 2015; 58: 60-63 [PMID: 25774197 DOI: 10.3345/ kjp.2015.58.2.60]
57. Katić BJ, Golden W, Cady RK, Hu XH. GERD prevalence in migraine patients and the implication for acute migraine treatment. J Headache Pain 2009; 10: 35-43 [PMID: 19009231 DOI: 10.1007/s10194-008-0083-1]
58. Abramson JH, Gofin J, Peritz E, Hopp C, Epstein LM. Clustering of chronic disorders-A community study of coprevalence in Jerusalem. J Chronic Dis 1982; 35: 221-230 [PMID: 7061679 DOI: 10.1016/0021-9681(82)90143-6]
59. Kurth T, Holtmann G, Neufang-Hüber J, Gerken G, Diener HC. Prevalence of unexplained upper abdominal symptoms in patients with migraine. Cephalalgia 2006; 26: 506-510 [PMID: 16674758 DOI: 10.1111/j.1468-2982.2005.01076.x]
60. Nilsson S, Edvinsson L, Malmberg B, Johansson B, Linde M. A relationship between migraine and biliary tract disorders: findings in two Swedish samples of elderly twins. Acta Neurol Scand 2010; 122: 286-294 [PMID: 20047569 DOI: 10.1111/ j.1600-0404.2009.01310.x]
61. Aggarwal N, Bielefeldt K. Diagnostic stringency and healthcare needs in patients with biliary dyskinesia. Dig Dis Sci 2013; 58: 2799-2808 [PMID: 23934412 DOI: 10.1007/s10620-013-2719-5]
62. Steiner TJ, Stovner LJ, Birbeck GL. Migraine: the seventh disabler. J Headache Pain 2013; 14: 1 [PMID: 23566305 DOI: 10.1186/1129-2377-14-1]
63. O'Connor TP, van der Kooy D. Enrichment of a vasoactive neuropeptide (calcitonin gene related peptide) in the trigeminal sensory projection to the intracranial arteries. J Neurosci 1988; 8: 2468-2476 [PMID: 2470872]
64. Kline LW, Pang PK. The effect of body weight on the calcitonin gene-related peptide-induced relaxation of guinea pig gallbladder strips. Regul Pept 1995; 59: 97-101 [PMID: 12506419 DOI: 10.10 16/0167-0115(95)00078-P]
65. Mulvihill SJ, Yan P. Impaired release of gallbladder calcitonin gene-related peptide in human gallstone disease. J Surg Res 1995; 58: 641-645 [PMID: 7791341 DOI: 10.1006/jsre.1995.1101]
66. Ruiz-Gayo M, González MC, Fernández-Alfonso S. Vasodilatory effects of cholecystokinin: new role for an old peptide? Regul Pept 2006; 137: 179-184 [PMID: 16889840 DOI: 10.1016/ j.regpep.2006.06.006]
67. Rodríguez RR, Saccone J, Véliz MA. Headache and liver disease: is their relationship more apparent than real? Dig Dis Sci 2004; 49: 1016-1018 [PMID: 15309894 DOI: 10.1023/B:DDAS.000003456 5.40011.60]
68. Celikbilek A, Celikbilek M, Okur A, Dogan S, Borekci E, Kozan M, Gursoy S. Non-alcoholic fatty liver disease in patients with migraine. Neurol Sci 2014; 35: 1573-1578 [PMID: 24756192 DOI: 10.1007/s10072-014-1798-1]
69. Ornello R, Ripa P, Pistoia F, Degan D, Tiseo C, Carolei A, Sacco S. Migraine and body mass index categories: a systematic review and meta-analysis of observational studies. J Headache Pain 2015; 16: 27 [PMID: 25903159 DOI: 10.1186/s10194-015-0510-z]
70. Verrotti A, Carotenuto M, Altieri L, Parisi P, Tozzi E, Belcastro V, Esposito M, Guastaferro N, Ciuti A, Mohn A, Chiarelli F, Agostinelli S. Migraine and obesity: metabolic parameters and response to a weight loss programme. Pediatr Obes 2015; 10: 220-225 [PMID: 24990114 DOI: 10.1111/ijpo.245]
71. Pilichiewicz AN, Little TJ, Brennan IM, Meyer JH, Wishart JM, Otto B, Horowitz M, Feinle-Bisset C. Effects of load, and duration, of duodenal lipid on antropyloroduodenal motility, plasma CCK and PYY, and energy intake in healthy men. Am J Physiol Regul Integr Comp Physiol 2006; 290: R668-R677 [PMID: 16210415 DOI: 10.1152/ajpregu.00606.2005]
72. Matzinger D, Degen L, Drewe J, Meuli J, Duebendorfer R, Ruckstuhl N, D'Amato M, Rovati L, Beglinger C. The role of long chain fatty acids in regulating food intake and cholecystokinin release in humans. Gut 2000; 46: 688-693 [PMID: 10764713 DOI: 10.1136/gut.46.5.689]
73. Ferrara LA, Pacioni D, Di Fronzo V, Russo BF, Speranza E, Carlino V, Gargiulo F, Ferrara F. Low-lipid diet reduces frequency and severity of acute migraine attacks. Nutr Metab Cardiovasc Dis 2015; 25: 370-375 [PMID: 25698152 DOI: 10.1016/ j.numecd.2014.12.006]
74. Green PH, Cellier C. Celiac disease. N Engl J Med 2007; 357: 1731-1743 [PMID: 17960014 DOI: 10.1056/NEJMra071600]
75. Bushara KO. Neurologic presentation of celiac disease. Gastroenterology 2005; 128: S92-S97 [PMID: 15825133 DOI: 10.1053/j.gastro.2005.02.018]
76. Serratrice J, Disdier P, de Roux C, Christides C, Weiller PJ. Migraine and coeliac disease. Headache 1998; 38: 627-628 [PMID: 11398309 DOI: 10.1046/j.1526-4610.1998.3808627.x]
77. D'Amico D, Rigamonti A, Spina L, Bianchi-Marzoli S, Vecchi M, Bussone G. Migraine, celiac disease, and cerebral calcifications: a new case. Headache 2005; 45: 1263-1267 [PMID: 16178961 DOI: 10.1111/j.1526-4610.2005.002532.x]
78. Benjilali L, Zahlane M, Essaadouni L. A migraine as initial presentation of celiac disease. Rev Neurol (Paris) 2012; 168: 454-456 [PMID: 22405455 DOI: 10.1016/j.neurol.2011.10.008]
79. Lahat E, Broide E, Leshem M, Evans S, Scapa E. Prevalence of celiac antibodies in children with neurologic disorders. Pediatr Neurol 2000; 22: 393-396 [PMID: 10913732 DOI: 10.1016/ S0887-8994(00)00129-6]
80. Schlesinger I, Hering R. Antigliadin antibodies in migraine patients. Cephalalgia 1997; 17: 712 [PMID: 9350395 DOI: 10.117 7/033310249701700616]
81. Armstrong D, Don-Wauchope AC, Verdu EF. Testing for glutenrelated disorders in clinical practice: the role of serology in managing the spectrum of gluten sensitivity. Can J Gastroenterol 2011; 25: 193-197 [PMID: 21523259 DOI: 10.1155/2011/642452]
82. Inaloo S, Dehghani SM, Farzadi F, Haghighat M, Imanieh MH. A comparative study of celiac disease in children with migraine headache and a normal control group. Turk J Gastroenterol 2011; 22: 32-35 [PMID: 21480108 DOI: 10.4318/tjg.2011.0153]
83. Alehan F, Ozçay F, Erol I, Canan O, Cemil T. Increased risk for coeliac disease in paediatric patients with migraine. Cephalalgia 2008; 28: 945-949 [PMID: 18624809 DOI: 10.1111/j.1468-2982.2008.01630.x]
84. Bürk K, Farecki ML, Lamprecht G, Roth G, Decker P, Weller M, Rammensee HG, Oertel W. Neurological symptoms in patients with biopsy proven celiac disease. Mov Disord 2009; 24: 2358-2362 [PMID: 19845007 DOI: 10.1002/mds.22821]
85. Dimitrova AK, Ungaro RC, Lebwohl B, Lewis SK, Tennyson CA, Green MW, Babyatsky MW, Green PH. Prevalence of migraine in patients with celiac disease and inflammatory bowel disease. Headache 2013; 53: 344-355 [PMID: 23126519 DOI: 10.1111/ j.1526-4610.2012.02260.x]
86. Lionetti E, Francavilla R, Maiuri L, Ruggieri M, Spina M, Pavone P, Francavilla T, Magistà AM, Pavone L. Headache in pediatric patients with celiac disease and its prevalence as a diagnostic clue. J Pediatr Gastroenterol Nutr 2009; 49: 202-207 [PMID: 19543115 DOI: 10.1097/MPG.0b013e31818f6389]
87. Gabrielli M, Cremonini F, Fiore G, Addolorato G, Padalino C, Candelli M, De Leo ME, Santarelli L, Giacovazzo M, Gasbarrini A, Pola P, Gasbarrini A. Association between migraine and Celiac disease: results from a preliminary case-control and therapeutic study. Am J Gastroenterol 2003; 98: 625-629 [PMID: 12650798 DOI: 10.1111/j.1572-0241.2003.07300.x]
88. Cicarelli G, Della Rocca G, Amboni M, Ciacci C, Mazzacca G, Filla A, Barone P. Clinical and neurological abnormalities in adult celiac disease. Neurol Sci 2003; 24: 311-317 [PMID: 14716525 DOI: 10.1007/s10072-003-0181-4]
89. Zelnik N, Pacht A, Obeid R, Lerner A. Range of neurologic disorders in patients with celiac disease. Pediatrics 2004; 113: 1672-1676 [PMID: 15173490 DOI: 10.1542/peds.113.6.1672]
90. Hadjivassiliou M, Grünewald RA, Lawden M, Davies-Jones GA, Powell T, Smith CM. Headache and CNS white matter abnormalities associated with gluten sensitivity. Neurology 2001; 56: 385-388 [PMID: 11171906 DOI: 10.1212/WNL.56.3.385]
91. Cady RK, Farmer K, Dexter JK, Hall J. The bowel and migraine: update on celiac disease and irritable bowel syndrome. Curr Pain Headache Rep 2012; 16: 278-286 [PMID: 22447132 DOI: 10.1007/s11916-012-0258-y]
92. Briani C, Zara G, Alaedini A, Grassivaro F, Ruggero S, Toffanin E, Albergoni MP, Luca M, Giometto B, Ermani M, De Lazzari F, D'Odorico A, Battistin L. Neurological complications of celiac disease and autoimmune mechanisms: a prospective study. J Neuroimmunol 2008; 195: 171-175 [PMID: 18343508 DOI: 10.1016/j.jneuroim.2008.01.008]
93. Mormile R. Celiac disease and migraine: is there a common backstage? Int J Colorectal Dis 2014; 29: 1571 [PMID: 24965856 DOI: 10.1007/s00384-014-1923-x]
94. Mayer EA, Tillisch K, Gupta A. Gut/brain axis and the microbiota. J Clin Invest 2015; 125: 926-938 [PMID: 25689247 DOI: 10.1172/ jci76304]
95. Hindiyeh N, Aurora SK. What the Gut Can Teach Us About Migraine. Curr Pain Headache Rep 2015; 19: 33 [PMID: 26049770 DOI: 10.1007/s11916-015-0501-4]
96. Matsumoto M, Kibe R, Ooga T, Aiba Y, Sawaki E, Koga Y, Benno Y. Cerebral low-molecular metabolites influenced by intestinal microbiota: a pilot study. Front Syst Neurosci 2013; 7: 9 [PMID: 23630473 DOI: 10.3389/fnsys.2013.00009]
97. Clarke G, Grenham S, Scully P, Fitzgerald P, Moloney RD, Shanahan F, Dinan TG, Cryan JF. The microbiome-gut-brain axis during early life regulates the hippocampal serotonergic system in a sex-dependent manner. Mol Psychiatry 2013; 18: 666-673 [PMID: 22688187 DOI: 10.1038/mp.2012.77]
98. Wikoff WR, Anfora AT, Liu J, Schultz PG, Lesley SA, Peters EC, Siuzdak G. Metabolomics analysis reveals large effects of gut microflora on mammalian blood metabolites. Proc Natl Acad Sci USA 2009; 106: 3698-3703 [PMID: 19234110 DOI: 10.1073/ pnas.0812874106]
99. Holzer P, Farzi A. Neuropeptides and the microbiota-gut-brain axis. Adv Exp Med Biol 2014; 817: 195-219 [PMID: 24997035 DOI: 10.1007/978-1-4939-0897-49]
100. Aguilera M, Vergara P, Martínez V. Environment-related adaptive changes of gut commensal microbiota do not alter colonic tolllike receptors but modulate the local expression of sensory-related systems in rats. Microb Ecol 2013; 66: 232-243 [PMID: 23666270 DOI: 10.1007/s00248-013-0241-0]
101. di Giancamillo A, Vitari F, Bosi G, Savoini G, Domeneghini C. The chemical code of porcine enteric neurons and the number of enteric glial cells are altered by dietary probiotics. Neurogastroenterol Motil 2010; 22: e271-e278 [PMID: 20524986 DOI: 10.1111/ j.1365-2982.2010.01529.x]
102. Kamm K, Hoppe S, Breves G, Schröder B, Schemann M. Effects of the probiotic yeast Saccharomyces boulardii on the neurochemistry of myenteric neurones in pig jejunum. Neurogastroenterol Motil 2004; 16: 53-60 [PMID: 14764205 DOI: 10.1046/j.1365-2982.2003.00458.x]
103. Tillisch K, Labus J, Kilpatrick L, Jiang Z, Stains J, Ebrat B, Guyonnet D, Legrain-Raspaud S, Trotin B, Naliboff B, Mayer EA. Consumption of fermented milk product with probiotic modulates brain activity. Gastroenterology 2013; 144: 1394-1401, 1401.e1-4 [PMID: 23474283 DOI: 10.1053/j.gastro.2013.02.043]
104. Roos NM, Giezenaar CG, Rovers JM, Witteman BJ, Smits MG, van Hemert S. The effects of the multispecies probiotic mixture Ecologic® Barrier on migraine: results of an open-label pilot study. Benef Microbes 2015; 6: 641-646 [PMID: 25869282 DOI: 10.3920/bm2015.0003]
105. Sensenig J, Johnson M, Staverosky T. Treatment of migraine with targeted nutrition focused on improved assimilation and elimination. Altern Med Rev 2001; 6: 488-494 [PMID: 11703169]